Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 07/01/2025 - 12/31/2025

Lobbyist name	Stephen Burm
Business name	Biotechnology Innovation Organization
Address	1201 New York Avenue, NW Suite 1300
City, state, zip code	Washington, DC 20005
Country	US
Agent type	Both
Phone	617-571-7232

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: Biotechnology Innovation Organization

Total amount paid by client; lobbyist is unable to report compensation at activity level: $3,004.81

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	1107	An Act prohibiting discrimination against 340b drug discount program participants	Oppose	$0.00	N/A
House Bill	1326	An Act to ensure access to prescription medications	Neutral	$0.00	N/A
Senate Bill	698	An Act relative to consumer deductibles	Support	$0.00	N/A
Senate Bill	847	An Act relative to rapid whole genome sequencing	Support	$0.00	N/A
Senate Bill	2619	An Act establishing the Massachusetts data privacy act	Neutral	$0.00	N/A
House Bill	4490	An Act prohibiting discrimination against 340b drug discount program participants	Oppose	$0.00	N/A
House Bill	4346	An Act to ensure access to prescription medications	Neutral	$0.00	N/A
House Bill	1384	An Act updating the health care cost growth benchmark and associated market oversight activities	Neutral	$0.00	N/A
House Bill	2384	An Act relative to provider choice	Support	$0.00	N/A
House Bill	4240	An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements, and for certain permanent improvements	Neutral	$0.00	N/A
House Bill	4495	An Act to protect 340B providers	Oppose	$0.00	N/A
House Bill	1322	An Act ensuring access to specialty medications	Neutral	$0.00	N/A
Senate Bill	1584	An Act to prevent undue influence on prescriber behavior	Neutral	$0.00	N/A
House Bill	1125	An Act relative to non-medical switching	Neutral	$0.00	N/A
Executive	Office of the Governor	Regulations or policies pertaining to drug innovation, pharmaceuticals, recycling and disposal, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, and patient access. Vaccine related issues.	Neutral	$0.00	N/A
Senate Bill	819	An Act prohibiting discrimination against 340b drug discount program participants	Oppose	$0.00	N/A
House Bill	4497	An Act ensuring access to specialty medications	Neutral	$0.00	N/A
Senate Bill	895	An Act to promote transparency and prevent price gouging of pharmaceutical drug prices	Neutral	$0.00	N/A
House Bill	4491	An Act relative to non-medical switching	Neutral	$0.00	N/A
Executive	Executive Office of Housing and Economic Development (EOHED)(Executive Office of Health and Human Services)	Initiatives in the life sciences industry around workforce training, investment tax credits, economic development incentive programs, R&D Tax credits, financing and Infrastructure grants. Massachusetts Life Sciences Center initiatives around internship programs, tax incentive programs, seed funding, and capital project grants.	Neutral	$0.00	N/A
House Bill	779	An Act to protect 340B providers in the MassHealth program	Oppose	$0.00	N/A
Senate Bill	875	An Act to promote transparency in prescription drug prices	Oppose	$0.00	N/A
Senate Bill	2509	An Act relative to the availability of prescription medication during an emergency	Neutral	$0.00	N/A
House Bill	4375	An Act to preserve and advance Massachusetts’ competitiveness in discovery, research, and innovation for a vibrant economy	Support	$0.00	N/A
Senate Bill	779	An Act to protect 340B providers	Oppose	$0.00	N/A
Senate Bill	734	An Act ensuring access to specialty medications	Neutral	$0.00	N/A
Senate Bill	895	An Act to promote transparency and prevent price gouging of pharmaceutical drug prices	Neutral	$0.00	N/A
Senate Bill	693	An Act relative to non-medical switching	Neutral	$0.00	N/A
Executive	Center for Health Information and Analysis (CHIA)	957 Code of Massachusetts Regulations 12.00 – Pharmacy Benefit Manager Reporting	Neutral	$0.00	N/A
Senate Bill	848	An Act relating to covered entity reporting to increase accountability to safeguard benefit for vulnerable patients	Neutral	$0.00	N/A
House Bill	1092	An Act to ensure affordable prescription medications through accountability standards	Neutral	$0.00	N/A
House Bill	1374	An Act establishing a state-wide drug repository program	Neutral	$0.00	N/A
House Bill	2430	An Act including Krabbe Disease in newborn screening	Neutral	$0.00	N/A
House Bill	1364	An Act relative to promoting healthcare access and affordability for patients	Support	$0.00	N/A
House Bill	1167	An Act to enact pharmacy benefit manager duties	Support	$0.00	N/A
House Bill	1080	An Act relative to copay assistance	Neutral	$0.00	N/A
House Bill	4339	An Act relative to patient access to biomarker testing to provide appropriate therapy	Support	$0.00	N/A
Senate Bill	1552	An Act relative to expanding the newborn screening panel	Neutral	$0.00	N/A
House Bill	1274	An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program	Oppose	$0.00	N/A
House Bill	1234	An Act relative to pharmacy benefit managers	Support	$0.00	N/A
House Bill	1101	An Act relative to consumer deductibles	Support	$0.00	N/A
House Bill	1368	An Act to provide rapid whole genome sequencing	Support	$0.00	N/A
House Bill	4367	An Act relative to newborn screenings for congenital cytomegalovirus	Neutral	$0.00	N/A
Senate Bill	845	An Act to protect 340B providers in the Medicaid program	Oppose	$0.00	N/A
House Bill	1325	An Act to ensure access to generic medication	Neutral	$0.00	N/A
Senate Bill	2035	An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing	Neutral	$0.00	N/A
House Bill	4616	An Act improving the health insurance prior authorization process	Neutral	$0.00	N/A
House Bill	1296	An Act to protect 340B providers	Oppose	$0.00	N/A
Senate Bill	827	An Act to ensure access to prescription medications	Neutral	$0.00	N/A
Senate Bill	1583	An Act to restore integrity in the marketing of pharmaceutical products and medical devices	Neutral	$0.00	N/A
Senate Bill	1514	An Act relative to provider choice	Support	$0.00	N/A
Executive	Executive Office of Labor and Workforce Development (EOLWD)	Initiatives around workforce training in the life sciences industry, including but not limited to non-four-year degree pathways with hands-on experience, partnerships with minority serving Institutions, increasing career awareness in younger students, and centralizing workforce development efforts.	Neutral	$0.00	N/A
Senate Bill	724	An Act promoting healthcare access and affordability for patients	Support	$0.00	N/A
House Bill	1334	An Act to enact pharmacy benefit manager duties	Neutral	$0.00	N/A
House Bill	4043	An Act relative to copay assistance for medications	Neutral	$0.00	N/A
Senate Bill	809	An Act relative to patient access to biomarker testing to provide appropriate therapy	Support	$0.00	N/A
Senate Bill	1573	An Act relative to newborn screenings for congenital cytomegalovirus	Neutral	$0.00	N/A
House Bill	4494	An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program	Oppose	$0.00	N/A
House Bill	1324	An Act relative to prescription drug pricing	Neutral	$0.00	N/A
House Bill	4333	An Act relative to consumer deductibles	Support	$0.00	N/A
Senate Bill	847	An Act relative to rapid whole genome sequencing	Support	$0.00	N/A
Senate Bill	2516	An Act establishing the Massachusetts data privacy act	Neutral	$0.00	N/A
House Bill	1082	An Act to enact the pharmacy benefit manager compensation reform	Support	$0.00	N/A
House Bill	4498	An Act to ensure affordable prescription medications through accountability standards	Neutral	$0.00	N/A
House Bill	1227	An Act relative to patient access to biomarker testing to provide appropriate therapy	Support	$0.00	N/A
Senate Bill	1530	An Act improving newborn screening tests	Neutral	$0.00	N/A
House Bill	785	An Act protecting 340B contract pharmacies	Oppose	$0.00	N/A
Senate Bill	694	An Act empowering health care consumers	Neutral	$0.00	N/A
Senate Bill	884	An Act to define modest meals and refreshments in prescriber education settings	Neutral	$0.00	N/A
House Bill	1136	An Act improving the health insurance prior authorization process	Neutral	$0.00	N/A
Senate Bill	868	An Act enhancing health care market oversight and pharmaceutical access	Oppose	$0.00	N/A
Senate Bill	868	An Act enhancing health care market oversight and pharmaceutical access	Oppose	$0.00	N/A
Senate Bill	904	An Act to strengthen health spending accountability processes within the health policy commission and the center for health information and analysis	Neutral	$0.00	N/A
House Bill	401	An Act to protect innovation and entrepreneurship in the Commonwealth	Oppose	$0.00	N/A
			Total amount	$0.00

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

No campaign contributions were filed for this disclosure reporting period.

Close this page

Connect with Us